Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on September 16, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on September 16, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 2,080 Common Stock at $498.45 ($1,036,777) on September 16, 2026; holds 331,863 after (Indirect).
- Open-market sale: disposed of 1,220 Common Stock at $499.15 ($608,966) on September 16, 2026; holds 330,643 after (Indirect).
- Open-market sale: disposed of 492 Common Stock at $500.19 ($246,096) on September 16, 2026; holds 330,151 after (Indirect).
- Open-market sale: disposed of 708 Common Stock at $501.52 ($355,077) on September 16, 2026; holds 329,443 after (Indirect).
- Open-market sale: disposed of 2,160 Common Stock at $502.44 ($1,085,272) on September 16, 2026; holds 327,283 after (Indirect).
- Open-market sale: disposed of 1,538 Common Stock at $503.53 ($774,429) on September 16, 2026; holds 325,745 after (Indirect).
- Open-market sale: disposed of 1,182 Common Stock at $504.17 ($595,932) on September 16, 2026; holds 324,563 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $505.20 ($60,624) on September 16, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on September 16, 2026; holds 423,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,763,172 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-09-16 | Open-market sale | Common Stock | 2,080 | $498 | $1.0M | 331,863 |
| 2026-09-16 | Open-market sale | Common Stock | 1,220 | $499 | $609.0K | 330,643 |
| 2026-09-16 | Open-market sale | Common Stock | 492 | $500 | $246.1K | 330,151 |
| 2026-09-16 | Open-market sale | Common Stock | 708 | $502 | $355.1K | 329,443 |
| 2026-09-16 | Open-market sale | Common Stock | 2,160 | $502 | $1.1M | 327,283 |
| 2026-09-16 | Open-market sale | Common Stock | 1,538 | $504 | $774.4K | 325,745 |
| 2026-09-16 | Open-market sale | Common Stock | 1,182 | $504 | $595.9K | 324,563 |
| 2026-09-16 | Open-market sale | Common Stock | 120 | $505 | $60.6K | 324,443 |
| 2026-09-16 | Option exercise/conversion | Stock Option | 9,500 | — | — | 423,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Option exercise/conversion (9,500 shares) |
| 2026-09-16 | Open-market sale (2,080 shares) |
| 2026-09-16 | Open-market sale (1,220 shares) |
| 2026-09-16 | Open-market sale (492 shares) |
| 2026-09-16 | Open-market sale (708 shares) |
| 2026-09-16 | Open-market sale (2,160 shares) |
| 2026-09-16 | Open-market sale (1,538 shares) |
| 2026-09-16 | Open-market sale (1,182 shares) |
| 2026-09-16 | Open-market sale (120 shares) |
| 2026-09-16 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.